When Kolmogorov-Smirnov and Shapiro-Wilk tests were applied for CCNB1 in the pTa, pT1, and pT2 cancer stage groups, the pT1 group, which included six patient samples, showed a normal distribution (p > 0.05), whereas the pTa and pT2 groups did not follow a normal distribution (p < 0.05) (Supplementary Figure S2). The gene discussed is CCNB1; the disease is cancer.